SCHEMBL29502160

SCHEMBL29502160

COC(=O)c1cc(OC)ccc1C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.62
CYP2C9 P11712 2/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2D6 P10635 1/20 0.62
CYP2C19 P33261 1/20 0.62
NR4A2 P43354 1/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
ALDH1A1 P00352 3/20 0.48
GAA P10253 2/20 0.48
GLA P06280 1/20 0.48
HSD17B10 Q99714 1/20 0.48
POLB P06746 2/20 0.47
HTT P42858 2/20 0.47
CYP3A4 P08684 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146258 1.00 KDM4E (0.62) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL14907284 0.89 KDM4E (0.49) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL16118574 0.85 NPC1 (0.47) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL1179412 0.85 HTT (0.58) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL382822 0.84 KDM4E (0.66) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL28365855 0.84 ALDH1A1 (0.54) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL21994466 0.84 ACHE (0.54) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL16540058 0.84 KDM4E (0.45) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19
SCHEMBL3481145 0.84 HPGD (0.58) KDM4ENPC1RAB9AL3MBTL1MEN1
SCHEMBL11615858 0.84 ALDH1A1 (0.46) KDM4ECYP2C9CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308557-A1 INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE Arvinas Operations, Inc. (US) 2024-01-24 EP disclosed
WO-2022198112-A1 INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-09-22 WO disclosed
EP-3989966-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2022-05-04 EP disclosed